Cucurbitacin e exhibits anti-inflammatory effect in RAW 264.7 cells via suppression of NF-κB nuclear translocation

Inflammation Research

Volumn 62, Issue 5, 2013, Pages 461-469

  Qiao, Jing ^a   Xu, Li Hui ^a   He, Jian ^a   Ouyang, Dong Yun ^a   He, Xian Hui ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Actin cytoskeleton; Cucurbitacin E; Lipopolysaccharides; NF B; RAW 264.7 cells

Indexed keywords

ANTIINFLAMMATORY AGENT; CUCURBITACIN; CUCURBITACIN E; G ACTIN; HELIUM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PROPIDIUM IODIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; TRITERPENE;

ACTIN FILAMENT; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL SPREADING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME PHOSPHORYLATION; G2 PHASE CELL CYCLE CHECKPOINT; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; MACROPHAGE; MTT ASSAY; NONHUMAN; PROTEIN AGGREGATION; PSEUDOPODIUM; ANIMAL; CELL CYCLE; CELL LINE; DRUG EFFECT; METABOLISM; MOUSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL CYCLE; CELL LINE; CELL PROLIFERATION; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MICE; NF-KAPPA B; TRITERPENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885624356     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-013-0598-z     Document Type: Article

References (31)

1. Chan KT, Li K, Liu SL, Chu KH, Toh M, Xie WD. Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562. Cancer Lett 2010;289:46-52.
2. Dong Y, Lu B, Zhang X, Zhang J, Lai L, Li D, Wu Y, Song Y, Luo J, Pang X, Yi Z, Liu M. Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway. Carcinogenesis 2010;31:2097-104.
3. Peters RR, Farias MR, Ribeiro-do-Valle RM. Anti-inflammatory and analgesic effects of cucurbitacins from Wilbrandia ebracteata. Planta Med 1997;63:525-8.
4. Duncan KL, Duncan MD, Alley MC, Sausville EA. Cucurbitacin E-induced disruption of the actin and vimentin cytoskeleton in prostate carcinoma cells. Biochem Pharmacol 1996;52:1553-60.
5. Abdelwahab SI, Hassan LE, Sirat HM, Yagi SM, Koko WS, Mohan S, Taha MM, Ahmad S, Chuen CS, Narrima P, Rais MM, Hadi AH. Anti-inflammatory activities of cucurbitacin E isolated from Citrullus lanatus var. citroides: role of reactive nitrogen species and cyclooxygenase enzyme inhibition. Fitoterapia 2011;82:1190-7.
6. Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Activation of innate immunity system during aging: NF-κB signaling is the molecular culprit of inflamm-aging. Ageing Res Rev 2008;7:83-105.
7. Sen R, Baltimore D. Inducibility of K immunoglobulin enhancerbinding protein NF-κB by a posttranslational mechanism. Cell 1986;47:921-8.
8. Karin M, Staudt L. NF-κB a network hub controlling immunity, inflammation, and cancer: a subject collection from Cold Spring Harbor perspectives in biology. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, NY; 2010. viii, p 271.
9. Karin M, Greten FR. NF kappa B: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005;5:749-59.
10. Liou H-C. NF-κB/Rel transcription factor family. Georgetown, Tex. New York: Landes Bioscience/Eurekah.com, Springer Science+Business Media, 2006. p 185.
11. Jin HR, Jin X, Dat NT, Lee JJ. Cucurbitacin B suppresses the transactivation activity of RelA/p65. J Cell Biochem 2011;112: 1643-50.
12. Zhang Y, Ouyang D, Xu L, Ji Y, Zha Q, Cai J, He X. Cucurbitacin B induces rapid depletion of the G-actin pool through reactive oxygen species-dependent actin aggregation in melanoma cells. Acta Biochim Biophys Sin 2011;43:556-67.
13. Zhang YT, Ouyang DY, Xu LH, Ji YH, Zha QB, Cai JY, He XH. Cucurbitacin B induces rapid depletion of the G-actin pool through reactive oxygen species-dependent actin aggregation in melanoma cells. Acta Biochim Biophys Sin 2011;43:556-67.
14. Ouyang D, Zhang Y, Xu L, Li J, Zha Q, He X. Histone deacetylase inhibitor valproic acid sensitizes B16F10 melanoma cells to cucurbitacin B treatment. Acta Biochim Biophys Sin 2011;43: 487-95.
15. Duncan MD, Duncan KL. Cucurbitacin E targets proliferating endothelia. J Surg Res 1997;69:55-60.
16. Jayaprakasam B, Seeram NP, Nair MG. Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana. Cancer Lett 2003;189:11-6.
17. Ziegler-Heitbrock H, Sternsdorf T, Liese J, Belohradsky B, Weber C, Wedel A, Schreck R, Bauerle P, Strobel M. Pyrrolidine dithiocarbamate inhibits NF-κB mobilization and TNF production in human monocytes. J Immunol 1993;151:6986-93.
18. Varfolomeev EE, Ashkenazi A. Tumor necrosis factor: an apoptosis JuNKie? Cell. 2004;116:491-7.
19. Nakashima S, Matsuda H, Kurume A, Oda Y, Nakamura S, Yamashita M, Yoshikawa M. Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells. Bioorg Med Chem Lett 2010;20:2994-7.
20. Sorensen PM, Iacob RE, Fritzsche M, Engen JR, Brieher WM, Charras G. Eggert US. ACS Chem Biol: The natural product cucurbitacin E inhibits depolymerization of actin filaments; 2012.
21. Momma K, Masuzawa Y, Nakai N, Chujo M, Murakami A, Kioka N, Kiyama Y, Akita T, Nagao M. Direct interaction of Cucurbitacin E isolated from Alsomitra macrocarpa to actin filament. Cytotechnology 2008;56:33-9.
22. Huang WW, Yang JS, Lin MW, Chen PY, Chiou SM, Chueh FS, Lan YH, Pai SJ, Tsuzuki M, Ho WJ, Chung JG. Cucurbitacin E induces G(2)/M phase arrest through STAT3/p53/p21 signaling and provokes apoptosis via Fas/CD95 and mitochondria-dependent pathways in human bladder cancer T24 cells. Evid Based Complement Alternat Med 2012;2012:952762.
23. Li Y, Wang R, Ma E, Deng Y, Wang X, Xiao J, Jing Y. The induction of G2/M cell-cycle arrest and apoptosis by cucurbitacin E is associated with increased phosphorylation of eIF2a in leukemia cells. Anticancer Drugs 2010;21:389-400.
24. Beutler B, Cerami A. The biology of cachectin/TNF-a primary mediator of the host response. Ann Rev Immunol 1989;7:625-55.
25. Verstrepen L, Bekaert T, Chau TL, Tavernier J, Chariot A, Beyaert R. TLR-4, IL-1R and TNF-R signaling to NF-κB: variations on a common theme. Cell Mol Life Sci 2008;65:2964-78.
26. Yang SK, Wang YC, Chao CC, Chuang YJ, Lan CY, Chen BS. Dynamic cross-talk analysis among TNF-R, TLR-4 and IL-1R signalings in TNF-α-induced inflammatory responses. BMC Med Genomics 2010;3:19.
27. Lee KC, Chang HH, Chung YH, Lee TY. Andrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-kappaB pathway. J Ethnopharmacol 2011;135:678-84.
28. O'Neill LAJ, Kaltschmidt C. NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 1997;20: 252-8.
29. Shrum CK, Defrancisco D, Meffert MK. Stimulated nuclear translocation of NF-κB and shuttling differentially depend on dynein and the dynactin complex. Proc Natl Acad Sci USA 2009;106:2647-52.
30. Rosette C, Karin M. Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa B. J Cell Biol 1995;128:1111-9.
31. Banan A, Keshavarzian A, Zhang L, Shaikh M, Forsyth C, Tang Y, Fields J. NF-κB activation as a key mechanism in ethanol-induced disruption of the F-actin cytoskeleton and monolayer barrier integrity in intestinal epithelium. Alcohol 2007;41:447-60.